Table 4.
Multivariate logistic regression for analyzing the risk factors for early death.
Variable | All-cause early death | Cancer-specific early death | ||||
---|---|---|---|---|---|---|
OR | 95%CI | P value | OR | 95%CI | P value | |
Race | ||||||
White | 1(ref) | 1(ref) | ||||
Black | 0.96 | 0.70-1.32 | 0.796 | 1.11 | 0.80-1.54 | 0.523 |
Other | 0.59 | 0.44-0.77 | <0.001 | 0.65 | 0.49-0.87 | 0.003 |
Primary site | ||||||
Cardia/fundus | 1(ref) | 1(ref) | ||||
Body | 1.31 | 0.90-1.91 | 0.152 | 1.22 | 0.83-1.80 | 0.308 |
Antrum/pylorus | 1.5 | 1.13-2.00 | 0.005 | 1.34 | 1.00-1.79 | 0.053 |
Lesser/greater curvature | 0.94 | 0.65-1.35 | 0.72 | 0.92 | 0.63-1.35 | 0.67 |
Other | 1.71 | 1.27-2.31 | <0.001 | 1.55 | 1.14-2.10 | 0.005 |
Differentiation grade | ||||||
I | 1(ref) | 1(ref) | ||||
II | 1.13 | 0.70-1.81 | 0.62 | 1.14 | 0.68-1.92 | 0.611 |
III | 1.54 | 0.97-2.44 | 0.069 | 1.63 | 0.99-2.68 | 0.056 |
IV | 1.74 | 0.78-3.89 | 0.176 | 1.58 | 0.68-3.69 | 0.292 |
AJCC Stage | ||||||
I | 1(ref) | 1(ref) | ||||
II | 1.07 | 0.70-1.63 | 0.758 | 0.75 | 0.49-1.17 | 0.203 |
III | 1.96 | 1.21-3.17 | 0.006 | 1.39 | 0.90-2.15 | 0.133 |
IV | 3.62 | 2.50-5.22 | <0.001 | 2.39 | 1.62-3.53 | <0.001 |
T stage | ||||||
T1 | 1(ref) | 1(ref) | ||||
T2 | 0.69 | 0.48-0.99 | 0.045 | 0.78 | 0.53-1.15 | 0.205 |
T3 | 0.87 | 0.60-1.25 | 0.444 | 1.03 | 0.71-1.49 | 0.895 |
T4 | 1.07 | 0.73-1.57 | 0.729 | 1.41 | 0.96-2.07 | 0.083 |
N stage | ||||||
N0 | 1(ref) | 1(ref) | ||||
N1 | 0.76 | 0.57-1.01 | 0.055 | NA | NA | NA |
N2 | 0.55 | 0.36-0.84 | 0.006 | NA | NA | NA |
N3 | 0.69 | 0.46-1.04 | 0.08 | NA | NA | NA |
Surgery | ||||||
No | 1(ref) | 1(ref) | ||||
Yes | 0.41 | 0.32-0.53 | <0.001 | 0.3 | 0.23-0.39 | <0.001 |
Chemotherapy | ||||||
No/Unknown | 1(ref) | 1(ref) | ||||
Yes | 0.14 | 0.11-0.18 | <0.001 | 0.16 | 0.13-0.21 | <0.001 |
Liver metastases | ||||||
No | 1(ref) | 1(ref) | ||||
Yes | NA | NA | NA | 1.48 | 1.02-2.14 | 0.039 |
OR, odds ratio; ref, reference. NA, not applicable.